Gonal-F Rff Redi-Ject (follitropin alfa, recombinant)
Follicle-Stimulating Hormone (FSH) Subcutaneous Pen Injector (ML)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: This medication contains follicle-stimulating hormone (FSH) and is used to treat certain fertility problems in women. Follitropin alfa helps stimulate healthy ovaries to produce eggs. This medication is usually used in combination with another hormone (hCG) to bring about the growth and release of a mature egg (ovulation).
This medication is not recommended for women whose ovaries no longer make eggs properly (primary ovarian failure).
Generic name: follitropin alfa, recombinant
Pronunciation: (FOL-i-TROE-pin AL-fa)
Drug class: Follicle-Stimulating Hormone (FSH)
Therapeutic class: Endocrine
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Gonal-F Rff Redi-Ject
Indications
The following indications are listed for Gonal-F Rff Redi-Ject:
- Follicle Stimulation For Assisted Fertilization Procedure
- Hypogonadotropic Hypogonadism
- Infertility Associated With Anovulation
Also known as: Infertility Associated With Ovulation Failure, Multifollicular Development For Assisted Reproductive Technologies.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Gonal-F Rff Redi-Ject 300 Unit | Maintenance | Inject 300 unit by subcutaneous route once daily. |
| Gonal-F Rff Redi-Ject 450 Unit | Maintenance | Inject 450 unit by subcutaneous route once daily. |
| Gonal-F Rff Redi-Ject 900 Unit | Maintenance | Inject 150 unit by subcutaneous route once daily. |
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Estrogen-dependent neoplasm
- Hormone receptor positive breast cancer
- Malignant neoplasm of the ovary
- Malignant neoplasm of the uterus
- Malignant tumor of testis
- Pituitary neoplasm
- Pregnancy
- Tumor of hypothalamus
- Abnormal uterine bleeding
- Acute respiratory distress syndrome
- Adrenocortical insufficiency
- Pituitary insufficiency
- Thromboembolic disorder
- Thrombophilia
- Torsion of ovary
- Untreated hypothyroidism
- Morbid obesity
- Ovarian hyperstimulation syndrome
Adverse reactions
There is no enhanced messaging for this drug.
More Frequent
- Ovarian cyst
- Ovarian enlargement
- Ovarian hyperstimulation syndrome
Less Frequent
- Hypotension
- Migraine
Rare or Very Rare
- Acute respiratory distress syndrome
- Anaphylaxis
- Arterial thrombosis
- Asthma exacerbation
- Cerebrovascular accident
- Dyspnea
- Hypersensitivity drug reaction
- Pulmonary thromboembolism
- Thromboembolic disorder
- Torsion of ovary
More Frequent
- Abdominal distension
- Abnormal vaginal bleeding
- Acne vulgaris
- Acute abdominal pain
- Diarrhea
- Flatulence
- Flu-like symptoms
- Headache disorder
- Mastalgia
- Mood changes
- Nausea
- Pelvic pain
- Pharyngitis
- Sinusitis
- Upper respiratory infection
Less Frequent
- Anorexia
- Candidiasis
- Chest pain
- Dizziness
- Drowsy
- Dysmenorrhea
- Dyspepsia
- Dysplasia of cervix
- Gynecomastia
- Injection site sequelae
- Nervousness
- Palpitations
- Polydipsia
- Pruritus of skin
- Vaginal discharge
- Vomiting
- Weight gain
Rare or Very Rare
- Facial edema
- Urticaria
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Follicle stimulation for assisted fertilization procedure | ||
| Z31.83 | ICD10CM | Encounter for assisted reproductive fertility procedure cycle |
| Z31.89 | ICD10CM | Encounter for other procreative management |
| Z52.81 | ICD10CM | Egg (oocyte) donor |
| Z52.810 | ICD10CM | Egg (oocyte) donor under age 35, anonymous recipient |
| Z52.811 | ICD10CM | Egg (oocyte) donor under age 35, designated recipient |
| Z52.812 | ICD10CM | Egg (oocyte) donor age 35 and over, anonymous recipient |
| Z52.813 | ICD10CM | Egg (oocyte) donor age 35 and over, designated recipient |
| Z52.819 | ICD10CM | Egg (oocyte) donor, unspecified |
| Hypogonadotropic hypogonadism | ||
| E23.0 | ICD10CM | Hypopituitarism |
| Infertility associated with anovulation | ||
| N97.0 | ICD10CM | Female infertility associated with anovulation |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.